Reetosh Pharmaceuticals Private Limited
About Reetosh Pharmaceuticals Private Limited
Data last updated:
Reetosh Pharmaceuticals Private Limited is a private limited company based in Ranchi, Jharkhand, India. It operates in the service-based operations segment of the business services sector. It was incorporated on 06 February 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Ranchi, under CIN U74999JH2018PTC010965. Its GSTIN is 20AAICR7494J1Z0 (Jharkhand).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Manish Kumar Alok and Smita Singh.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C – 304 Bansal Plaza Station Road, Ranchi, Jharkhand, India – 834001.
As per the financials filed for FY 2025, the company reported a revenue of ₹62.54 Lakh, a growth of 16% compared to the previous year. For the same year it recorded a net profit of ₹1.62 Lakh (net margin 2.6%) and EBITDA of ₹3.62 Lakh (EBITDA margin 5.8%). Revenue has grown at a compounded annual rate (CAGR) of 26% over three years and 29% over five years.
As per MCA filings, the company has open charges of ₹10 Lakh on record.
Company details
Contact details
Reetosh Pharmaceuticals Private Limited's registered office is in Ranchi, Jharkhand. Its e-mail address is in the company report.
- Email
- Registered AddressC – 304 Bansal Plaza Station Road, Ranchi, Jharkhand, India – 834001
- IndustryBusiness Services, Other Services, Miscellaneous Business Activities
To see the full contact details of Reetosh Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Reetosh Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Reetosh Pharmaceuticals Private Limited, buy the company report.
Financials of Reetosh Pharmaceuticals Private Limited
FY 2025 filings availableReetosh Pharmaceuticals Private Limited reported revenue of ₹62.54 Lakh (up 16% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 29% over five years, including 16% growth in the latest year. EBITDA rose 14% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹3.62 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.62 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.8% | ||||
| Net Profit Margin | 2.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Reetosh Pharmaceuticals Private Limited, buy the company report.
Board of directors of Reetosh Pharmaceuticals Private Limited
Reetosh Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Manish Kumar Alok | Director | 06 Feb 2018 | 8 Years 8 Months | Current |
| Smita Singh | Director | 06 Feb 2018 | 8 Years 8 Months | Current |
Peer comparison
Reetosh Pharmaceuticals Private Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Innings Pharmaceuticals Private Limited | ₹62.87 Lakh (FY 2025) | 9.0% | Delhi, India | |||
| Organcare Pharmaceuticals Private Limited | ₹62.81 Lakh (FY 2025) | 28.0% | Indore, Madhya Pradesh, India | |||
| Fizex Pharmaceuticals Private Limited | ₹62.62 Lakh (FY 2018) | 232.0% | Patna, Bihar, India | |||
| Perron Pharmaceuticals Private Limited | ₹62.59 Lakh (FY 2025) | 13.0% | Delhi, India | |||
| Reetosh Pharmaceuticals Private Limitedthis company | ₹62.54 Lakh (FY 2025) | ₹1.62 Lakh | 2.6% | 16.0% | Ranchi, Jharkhand, India | |
| Allegro Pharmaceuticals Private Limited | ₹62.32 Lakh (FY 2023) | 3.0% | Kozhikode, Kerala, India | |||
| Nevcare Pharmaceuticals Private Limited | ₹62.24 Lakh (FY 2024) | 155.0% | Thane, Maharashtra, India | |||
| Rozer Pharmaceuticals Private Limited | ₹62.21 Lakh (FY 2025) | 22.0% | Kalyan, Maharashtra, India |
To see the full peer comparison of Reetosh Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 06 Sep 2024 | 101002507 | Others | ₹10 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Reetosh Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Reetosh Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Reetosh Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 20AAICR7494J1Z0 | Jharkhand | Active | 28 Feb 2018 |
To see the full GST registrations and return filing status of Reetosh Pharmaceuticals Private Limited, buy the company report.
Recent activity
Reetosh Pharmaceuticals Private Limited has 2 board changes on record since 2018: 2 appointments. The latest: Manish Kumar Alok was appointed as Director on 06 Feb 2018.
Frequently asked questions
Reetosh Pharmaceuticals is an active private limited company based in Ranchi, Jharkhand, India. The company works in other services, within the business services industry. It was incorporated on 06 February 2018 (8+ years old) and is registered under CIN U74999JH2018PTC010965.
Reetosh Pharmaceuticals has 2 current directors:
- Manish Kumar Alok - Director
- Smita Singh - Director
The latest financial statements of Reetosh Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Reetosh Pharmaceuticals is 20AAICR7494J1Z0, registered in Jharkhand.
The CIN (Corporate Identification Number) of Reetosh Pharmaceuticals is U74999JH2018PTC010965. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Reetosh Pharmaceuticals was incorporated on 06 February 2018, making it 8+ years old. It is registered with the Registrar of Companies, Ranchi.
The peers of Reetosh Pharmaceuticals by revenue are Innings Pharmaceuticals Private Limited, Organcare Pharmaceuticals Private Limited, Fizex Pharmaceuticals Private Limited, Perron Pharmaceuticals Private Limited, Allegro Pharmaceuticals Private Limited and 2 more, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Manish Kumar Alok was appointed as Director on 06 Feb 2018. Smita Singh was appointed as Director on 06 Feb 2018.
The registered office of Reetosh Pharmaceuticals is at C – 304 Bansal Plaza Station Road, Ranchi, Jharkhand, India – 834001.
Reetosh Pharmaceuticals operates in the business services industry, in the other services segment.
Reetosh Pharmaceuticals has open charges of ₹10 Lakh and no satisfied charges on record as per latest MCA filings.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
